...
首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats.
【24h】

Systemic factors are involved in the pathogenesis of proteinuria-induced glomerulosclerosis in adriamycin nephrotic rats.

机译:系统性因素参与阿霉素肾病大鼠蛋白尿诱导的肾小球硬化的发病机理。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

This study aims to dissociate the respective roles of systemic nephrosis and of the intrarenal effects of proteinuria in the pathogenesis of focal segmental glomerulosclerosis (FGS) in adriamycin nephrosis. To this purpose, this study examined proteinuria and FGS in bilateral (BAP) and unilateral proteinuria (UAP) in two different rat strains. UAP was obtained by protecting one kidney from exposure to adriamycin by temporary clipping of one renal artery during adriamycin injection. At sacrifice (week 12), FGS was present in BAP and in exposed kidneys in UAP, but not in unexposed kidneys. FGS correlated significantly with proteinuria per kidney in BAP and UAP. Remarkably, for a given proteinuria per kidney, the sclerosis score was higher in BAP than in UAP, reflected by a higher ratio of FGS score per mg proteinuria per kidney (Wistar: 0.09 +/- 0.01 in BAP versus 0.05 +/- 0.01%/mg protein per d in UAP, P < 0.05; Lewis: 0.12 +/- 0.01 in BAP versus 0.07 +/- 0.01%/mg protein per d in UAP, P < 0.05), indicating that the local damaging effects of proteinuria are modified by other factors. Cholesterol correlated with total proteinuria in BAP and UAP. FGS score was positively correlated with cholesterol. The latter correlation was similar in BAP and UAP, indicating that cholesterol was a more uniform predictor for FGS than proteinuria per kidney. This was independent of strain-specific factors. On multilinear regression analysis, cholesterol turned out to be the most consistent predictor of FGS in proteinuric kidneys, with a stronger predictive value than proteinuria per kidney. It is concluded that although systemic sequelae of nephrosis do not induce renal damage in nonproteinuric kidneys, they modify the severity of proteinuria-induced FGS in proteinuric kidneys.
机译:这项研究旨在分离全身性肾病和蛋白尿的肾内作用在阿霉素肾病中局灶节段性肾小球硬化症(FGS)发病机理中的作用。为此,本研究检查了两种不同大鼠品系中的双侧蛋白尿和FGS和单侧蛋白尿(UAP)。通过在注射阿霉素期间临时截断一只肾动脉来保护一个肾脏免于暴露于阿霉素而获得UAP。处死(第12周)时,FAP存在于BAP和UAP暴露的肾脏中,但未暴露于未暴露的肾脏中。 FGS与BAP和UAP中每个肾脏的蛋白尿显着相关。值得注意的是,对于给定的每个肾脏蛋白尿,BAP的硬化评分高于UAP,反映为FGS评分/肾脏每毫克蛋白尿的比例更高(Wistar:BAP为0.09 +/- 0.01,而0.05 +/- 0.01% / mg UAP中蛋白/ d,P <0.05; Lewis:BAP中0.12 +/- 0.01%,而UAP中蛋白/ d为0.07 +/- 0.01%/ mg,P <0.05),表明蛋白尿的局部破坏作用是被其他因素修改。胆固醇与BAP和UAP中的总蛋白尿相关。 FGS评分与胆固醇呈正相关。在BAP和UAP中,后者的相关性相似,表明胆固醇比每个肾脏的蛋白尿更能预测FGS。这与菌株特异性因素无关。在多线性回归分析中,胆固醇被证明是蛋白尿肾脏中FGS的最一致预测指标,其预测价值高于每个肾脏的蛋白尿。结论是,尽管肾病的系统性后遗症在非蛋白尿性肾脏中不引起肾脏损害,但它们改变了蛋白尿症引起的蛋白尿引起的FGS的严重性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号